Sign In
Buy CSTL
$24.69
-0.795 (-3.12%)
At Close: Jul 24, 2026
Castle Biosciences to Release Third Quarter 2021 Financial Results and Host Conference Call on Monday, Nov. 8, 2021
07:00am, Monday, 25'th Oct 2021
FRIENDSWOOD, Texas--(BUSINESS WIRE)---- $CSTL #DecisionDxMelanoma--Castle will release its financial results for the third quarter and nine months ended Sept. 30, 2021, after the close of market on No
Castle Biosciences Awarded U.S. Federal Supply Schedule Contract for DecisionDx-Melanoma
07:00am, Tuesday, 24'th Aug 2021
FRIENDSWOOD, Texas--(BUSINESS WIRE)---- $CSTL #CSTL--Castle announced that it has been awarded a five-year U.S. Federal Supply Schedule (FSS) contract for its DecisionDx®-Melanoma test.
Castle Biosciences, Inc (CSTL) CEO Derek Maetzold on Q2 2021 Results - Earnings Call Transcript
10:33am, Wednesday, 11'th Aug 2021
Castle Biosciences, Inc (CSTL) CEO Derek Maetzold on Q2 2021 Results - Earnings Call Transcript
Castle Biosciences Q2 Earnings Edges Out Expectation On Record Test Report Volume
05:41pm, Tuesday, 10'th Aug 2021
After the market close on Monday, Castle Biosciences Inc (NASDAQ: CSTL) reported that its second-quarter revenues rose 79% Y/Y to $22.75 million, beating the consensus of $18.93 million. The increa
Castle Biosciences, Inc. (CSTL) Reports Q2 Loss, Tops Revenue Estimates
07:59pm, Monday, 09'th Aug 2021
Castle Biosciences, Inc. (CSTL) delivered earnings and revenue surprises of -17.24% and 19.21%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stoc
Castle Biosciences to Present Data at the 2021 American Academy of Dermatology (AAD) Summer Meeting
07:00am, Friday, 06'th Aug 2021
FRIENDSWOOD, Texas--(BUSINESS WIRE)---- $CSTL #DecisionDxMelanoma--Castle Biosciences announced oral data presentations on two of its skin cancer gene expression profile tests during the 2021 AAD Summ
Analysts Estimate Castle Biosciences, Inc. (CSTL) to Report a Decline in Earnings: What to Look Out for
04:45pm, Monday, 02'nd Aug 2021
Castle Biosciences, Inc. (CSTL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Castle Biosciences Collaborates with the Melanoma Research Foundation
07:00am, Monday, 02'nd Aug 2021
FRIENDSWOOD, Texas--(BUSINESS WIRE)---- $CSTL #DecisionDxMelanoma--Castle today announced its continued collaboration with the Melanoma Research Foundation (MRF).
Castle Biosciences to Release Second Quarter 2021 Financial Results and Host Conference Call on Monday, Aug. 9, 2021
07:00am, Monday, 26'th Jul 2021
FRIENDSWOOD, Texas--(BUSINESS WIRE)---- $CSTL #castlebiosciences--Castle Biosciences announced that it will release its financial results for the second quarter and six months ended June 30, 2021 on A
Castle Biosciences Presents Data on DecisionDx®-Melanoma and DecisionDx®-SCC at SDPA Annual Summer Dermatology Conference 2021
05:00pm, Thursday, 22'nd Jul 2021
FRIENDSWOOD, Texas--(BUSINESS WIRE)---- $CSTL #SDPA--Castle Biosciences announced data presentations at the Society of Dermatology Physician Assistants (SDPA) Annual Summer Dermatology Conference 2021
Castle Biosciences Expands its Board of Directors with New Appointments
07:00am, Friday, 16'th Jul 2021
FRIENDSWOOD, Texas--(BUSINESS WIRE)---- $CSTL #boardofdirectors--Castle announced that Kim Caple and Ellen Goldberg have been appointed to its board of directors, effective immediately.
AltheaDx, Inc. appoints industry veteran Derek Maetzold to its Board of Directors
12:42pm, Wednesday, 26'th May 2021
SAN DIEGO, May 26, 2021 /PRNewswire/ -- AltheaDx, a commercial stage, precision medicine company with the world's leading pharmacogenomics test for anxiety and depression announced today that it h
Castle Biosciences Supports the American Skin Association with Research Grant
07:00am, Friday, 21'st May 2021
FRIENDSWOOD, Texas--(BUSINESS WIRE)---- $CSTL #AmericanSkinAssociation--Castle today announced its collaboration with the American Skin Association to provide a 2021 research grant in the area of mela
Castle Biosciences, Inc (CSTL) CEO Derek Maetzold on Q1 2021 Results - Earnings Call Transcript
10:33pm, Monday, 10'th May 2021
Castle Biosciences, Inc (CSTL) CEO Derek Maetzold on Q1 2021 Results - Earnings Call Transcript
Castle Biosciences, Inc. (CSTL) Reports Q1 Loss, Tops Revenue Estimates
06:47pm, Monday, 10'th May 2021
Castle Biosciences, Inc. (CSTL) delivered earnings and revenue surprises of 22.73% and 33.14%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stoc
